DCF — CHI HEALTH ST. ELIZABETH
Enterprise Value: $-343.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-343.5M
Enterprise Value
$-107.1M
PV of Cash Flows
$-236.4M
PV of Terminal Value
$-380.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $168.5M | $-22.3M | -13.0% | $-29.4M | $-26.7M |
| Year 2 | $173.5M | $-21.2M | -12.0% | $-28.5M | $-23.6M |
| Year 3 | $178.7M | $-20.0M | -11.0% | $-27.6M | $-20.7M |
| Year 4 | $184.1M | $-19.7M | -11.0% | $-27.5M | $-18.8M |
| Year 5 | $189.6M | $-19.8M | -10.0% | $-27.9M | $-17.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-343.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$163.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1370696162654546
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5